These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 38691482)
1. Therapeutic Drug Monitoring of Levetiracetam in Different Trimesters of Pregnant Women with Epilepsy in a Tertiary Care Center: A Prospective Study. Kumaravel J; Sarma P; Suri V; Singh P; Prakash A; Medhi B Neurol India; 2024 Mar; 72(2):358-363. PubMed ID: 38691482 [TBL] [Abstract][Full Text] [Related]
2. AntiEpileptic drug Monitoring in PREgnancy (EMPiRE): a double-blind randomised trial on effectiveness and acceptability of monitoring strategies. Thangaratinam S; Marlin N; Newton S; Weckesser A; Bagary M; Greenhill L; Rikunenko R; D'Amico M; Rogozińska E; Kelso A; Hard K; Coleman J; Moss N; Roberts T; Middleton L; Dodds J; Pullen A; Eldridge S; Pirie A; Denny E; McCorry D; Khan KS Health Technol Assess; 2018 May; 22(23):1-152. PubMed ID: 29737274 [TBL] [Abstract][Full Text] [Related]
3. Monitoring levetiracetam concentration in saliva during pregnancy is stable and feasible. Li W; Yang X; Chen Q; Wang Z; Duan Y; Chen L CNS Neurosci Ther; 2024 Jul; 30(7):e14827. PubMed ID: 38992878 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic drug monitoring in pregnancy: Levetiracetam. Fallik N; Trakhtenbroit I; Fahoum F; Goldstein L Epilepsia; 2024 May; 65(5):1285-1293. PubMed ID: 38400747 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic Drug Monitoring of Antiepileptic Drugs in Women with Epilepsy Before, During, and After Pregnancy. Arfman IJ; Wammes-van der Heijden EA; Ter Horst PGJ; Lambrechts DA; Wegner I; Touw DJ Clin Pharmacokinet; 2020 Apr; 59(4):427-445. PubMed ID: 31912315 [TBL] [Abstract][Full Text] [Related]
6. Antiepileptic drug clearances during pregnancy and clinical implications for women with epilepsy. Voinescu PE; Park S; Chen LQ; Stowe ZN; Newport DJ; Ritchie JC; Pennell PB Neurology; 2018 Sep; 91(13):e1228-e1236. PubMed ID: 30185446 [TBL] [Abstract][Full Text] [Related]
7. Levetiracetam use in pregnancy. Longo B; Forinash AB; Murphy JA Ann Pharmacother; 2009 Oct; 43(10):1692-5. PubMed ID: 19690219 [TBL] [Abstract][Full Text] [Related]
8. Levetiracetam Clinical Pharmacokinetic Monitoring in Pediatric Patients with Epilepsy. Tan J; Paquette V; Levine M; Ensom MHH Clin Pharmacokinet; 2017 Nov; 56(11):1267-1285. PubMed ID: 28353057 [TBL] [Abstract][Full Text] [Related]
9. Factors influencing serum concentrations of levetiracetam in dogs with epilepsy. Saint-Maxent M; Juette T; Parent J; Castel A; Parmentier T J Vet Intern Med; 2024; 38(4):2249-2256. PubMed ID: 38888491 [TBL] [Abstract][Full Text] [Related]
10. Increased levetiracetam clearance associated with a breakthrough seizure in a pregnant patient receiving once/day extended-release levetiracetam. Garrity LC; Turner M; Standridge SM Pharmacotherapy; 2014 Jul; 34(7):e128-32. PubMed ID: 24807683 [TBL] [Abstract][Full Text] [Related]
11. Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy. Reisinger TL; Newman M; Loring DW; Pennell PB; Meador KJ Epilepsy Behav; 2013 Oct; 29(1):13-8. PubMed ID: 23911354 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic drug monitoring of levetiracetam by high-performance liquid chromatography with photodiode array ultraviolet detection: preliminary observations on correlation between plasma concentration and clinical response in patients with refractory epilepsy. Lancelin F; Franchon E; Kraoul L; Garciau I; Brovedani S; Tabaouti K; Landré E; Chassoux F; Paubel P; Piketty ML Ther Drug Monit; 2007 Oct; 29(5):576-83. PubMed ID: 17898647 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic Variability During Long-Term Therapeutic Drug Monitoring of Valproate, Clobazam, and Levetiracetam in Patients With Dravet Syndrome. Johannessen Landmark C; Heger K; Lund C; Burns ML; Bjørnvold M; Sætre E; Johannessen SI Ther Drug Monit; 2020 Oct; 42(5):744-753. PubMed ID: 32558674 [TBL] [Abstract][Full Text] [Related]
15. Levetiracetam therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs. Contin M; Albani F; Riva R; Baruzzi A Ther Drug Monit; 2004 Aug; 26(4):375-9. PubMed ID: 15257066 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic variability of four newer antiepileptic drugs, lamotrigine, levetiracetam, oxcarbazepine, and topiramate: a comparison of the impact of age and comedication. Johannessen Landmark C; Baftiu A; Tysse I; Valsø B; Larsson PG; Rytter E; Johannessen SI Ther Drug Monit; 2012 Aug; 34(4):440-5. PubMed ID: 22777154 [TBL] [Abstract][Full Text] [Related]
17. Levetiracetam use during pregnancy in women with epilepsy: Preliminary observations from a tertiary care center in Northern India. Bansal R; Suri V; Chopra S; Aggarwal N; Sikka P; Saha SC; Goyal MK; Kumar P Indian J Pharmacol; 2018; 50(1):39-43. PubMed ID: 29861526 [TBL] [Abstract][Full Text] [Related]
18. Correlation of levetiracetam concentration in peripheral blood mononuclear cells with clinical efficacy: A sensitive monitoring biomarker in patients with epilepsy. Harby SA; Nassra RA; Mekky JF; Ali SM; Ismail CA Seizure; 2020 May; 78():71-77. PubMed ID: 32213443 [TBL] [Abstract][Full Text] [Related]